Reduction in systolic blood pressure in hypertensive individuals and oxidized LDL in 93 overweight individuals with CVD risk.
![](http://decodeage.com/cdn/shop/files/1_Backed_by_Science_225ef2ef-31fa-4593-9bde-199a420e1231.webp?v=1731998641)
![](http://decodeage.com/cdn/shop/files/2_Backed_by_Science_6deb0409-9e22-464f-89ce-594e7e7b267a.webp?v=1731998641)
Reduction in URTI severity and sick days in physically fit adults aged 40 and older at 1,000 mg/day for 12 weeks.
![](http://decodeage.com/cdn/shop/files/3_Backed_by_Science_c417be0f-1103-4009-8849-66a19f202626.webp?v=1731998641)
In upper respiratory tract infections (URTI) incidence in male cyclists after intensive exercise.
![](http://decodeage.com/cdn/shop/files/4_Backed_by_Science_7c3469fc-a614-451f-a2dd-6086966d9b29.webp?v=1731998640)
In blood pressure in stage 1 hypertensive patients with Quercetin supplementation (730 mg/d) for 28 days.